Top Buy
| Security ▼ | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Ocuphire Pharma Inc. | 16 | 1 | 10 | 0 | €1.84 | €3.50 | 89.805% |
| Novo Nordisk A/S ADR | 39 | 1 | 22 | 0 | €124.50 | €150.00 | 20.482% |
| Novo Nordisk A/S | 5 | 0 | 1 | 0 | €185.00 | €195.00 | 5.405% |
| Novocure Ltd | 1 | 1 | 0 | 0 | €17.69 | - | - |
| Novavax Inc. | 7 | 10 | 3 | 10 | €14.45 | €10.50 | -27.336% |
| Novartis AG ADR | 21 | 1 | 19 | 1 | €102.00 | €110.00 | 7.843% |
| Neurocrine Bioscience | 53 | 0 | 22 | 0 | €131.45 | €150.00 | 14.112% |
| Nektar Therapeutics | 4 | 1 | 1 | 0 | €1.32 | €2.40 | 82.232% |
| Natural Alternat. | 20 | 1 | 3 | 0 | €5.05 | - | - |
| Nanorepro AG | 5 | 1 | 4 | 1 | €1.81 | €2.20 | 21.884% |
| Nanobiotix | 11 | 0 | 11 | 0 | €4.73 | €7.00 | 48.054% |
| MPH Health Care AG | 1 | 0 | 0 | 0 | €25.20 | - | - |
| MorphoSys AG | 7 | 11 | 0 | 11 | €67.20 | €65.00 | -3.274% |
| Merck KGaA | 11 | 5 | 8 | 4 | €155.25 | €178.00 | 14.654% |
| Merck & Co. Inc. | 49 | 1 | 20 | 0 | €115.00 | €125.66 | 9.268% |
| Medpace Holdings Inc | 13 | 0 | 2 | 0 | €405.80 | €420.00 | 3.499% |
| Medigene AG | 20 | 1 | 19 | 0 | €1.21 | €1.50 | 23.967% |
| MannKind Corp. | 9 | 0 | 0 | 0 | €5.51 | €6.43 | 16.779% |
| Madrigal Pharmaceuticals inc. | 13 | 1 | 10 | 1 | €243.50 | €310.00 | 27.310% |
| MacroGenics Inc. | 13 | 0 | 0 | 0 | €4.94 | €12.42 | 151.512% |
| Lisata Therapeutics Inc. | 1 | 0 | 0 | 0 | €3.34 | €4.00 | 19.760% |
| Lexicon Pharmaceuticals Inc. | 5 | 0 | 3 | 0 | €1.99 | €9.17 | 361.965% |
| Laboratorios Farmaceuticos | 1 | 0 | 0 | 0 | €86.00 | €100.00 | 16.279% |
| Krystal Biotech | 17 | 0 | 0 | 0 | €188.05 | €186.59 | -0.776% |
| Knight Therapeutics | 1 | 0 | 0 | 0 | €3.92 | €10.00 | 155.102% |